Leadership
Ezra Felker, MBA
President, CEO, and Founder
Ezra Felker is an experienced biotechnolgoy executive with over 30 years in early stage companies spanning positions in busines development, finance, operations, and R&D.
Most recently, Ezra was the COO of Venatorx Pharmaceuticals, where he helped the company raise over $500M in public and private capital. Previously, Ezra worked with NuPathe, BTG plc, Icagen, Athersys, and Biosite Diagnostics.
Paul Lieberman, Ph.D.
Founder and Advisor
Paul M. Lieberman, PhD is the Hilary Koprowski Endowed Chair and Professor at the Wistar Institute and member of the Department of Microbiology at the University of Pennsylvania. He received a PhD from The Johns Hopkins School of Medicine in Pharmacology and Virology. He is an Elected Fellow of the American Association for the Advancement of Science. His research focuses on the role of Epstein-Barr Virus in cancer and autoimmunity.
Troy Messic, Ph.D.
Founder and Advisor
Troy Messick, Ph.D., is a trained structural biologist with expertise in pharmacology, cancer biology, and virology. He is experienced in drug discovery research including, assay development, hit-to-lead chacterization, structure based drug design, and lead optimization.
Dr. Messick had led EBNA1 program from basic research through preclinical development and into clinical trials.
Dr. Messick’s work has led to 4 filed patents.